In Margaret
Sleeboom-Faulkner’s “Regulating cell lives in Japan: avoiding scandal and
sticking to nature,” I found the discussions about the official and public stances
on hESR (human embryonic stem cell research) especially intriguing. After the
Cabinet’s Council for Science and Technology Policy (CSTP) voted in favor of the
use of hES cells from aborted fetuses to better scientific research in 2004, there
were a variety of responses to the important decision. The CSTP’s intention was
to improve laboratory and clinical research by restricting hES cell lines to
only curing “serious diseases, and only if detailed informed consent procedures
using a coordinator would be followed” (232). This was accomplished by the CSTP
having its Bioethics Expert Panel create the guidelines for therapeutic
cloning, known as the Interim Report Working Group of Therapeutic Cloning.
I am surprised that the
author states, “The public discussion on hESR in Japan is limited” (232). It
seems that such a significant decision for a country should have led to more of
a response. Sleeboom-Faulkner continues, “Only the views of a few groups, such
as the anti-eugenics network, the Soshiren (Japanese women’s movement), some
patient movements, and religious groups were voiced in the media” (232). It is
understandable that there are different types of reactions to the CSTP’s
decision, but I expected that there would be a higher sense of urgency.
Sleeboom-Faulkner explains, “The low-key nature of the debate, according to
group discussions held in December 2008, was due to the general aversion among
Japanese people to “unnatural” practices and “high-tech” and “commercial”
attitudes towards life, a view also voiced among some members of disabled movements”
(233). There are many opinions with regard to how to use the hES cells,
including restricting them to only assisting your kind. However, it seems that
for a country so advanced in the realm of technology, the people should voice
their opinion more loudly over this issue than they are doing now.
No comments:
Post a Comment